Viable Threat (Outbreak Task Force)

(2)
Viable Threat (Outbreak Task Force) image
ISBN-10:

1544851553

ISBN-13:

9781544851556

Author(s): Rowe, Julie
Released: Mar 23, 2017
Format: Paperback, 360 pages

Description:

Special Forces soldier and medic Walter River would give anything to snatch more than a few seconds of down time to see if he can rattle the no-nonsense and incredibly hot Dr. Lloyd he's protecting, but dodging explosions, snipers, and student radicals who've unleashed a lethal bio-engineered microorganism have made that almost impossible. Maybe he'll get a chance—if he can figure out how to keep them both alive.

CDC microbiologist Ava Lloyd races to find a cure for a bio-terrorism organism sweeping El Paso. The few stolen moments with her very hunky bodyguard River have been explosive, but no matter how alluring he is, she can't afford to get distracted. The clock is ticking, people are dying by the hundreds, and once this crisis is solved, they'll both be off on their next assignment, thousands of miles apart.

Best prices to buy, sell, or rent ISBN 9781544851556




Frequently Asked Questions about Viable Threat (Outbreak Task Force)

You can buy the Viable Threat (Outbreak Task Force) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $17.98 on Amazon and is available from 8 sellers at the moment.

If you’re interested in selling back the Viable Threat (Outbreak Task Force) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Viable Threat (Outbreak Task Force) book, the best buyback offer comes from and is $ for the book in good condition.

The Viable Threat (Outbreak Task Force) book is in very low demand now as the rank for the book is 2,910,608 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.